BIOREM INC (BRM.CA) Fundamental Analysis & Valuation

TSX-V:BRM • CA09068G1046

Current stock price

2.6 CAD
+0.11 (+4.42%)
Last:

This BRM.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

9

1. BRM.CA Profitability Analysis

1.1 Basic Checks

  • In the past year BRM was profitable.
  • In the past year BRM had a positive cash flow from operations.
  • BRM had positive earnings in each of the past 5 years.
  • BRM had a positive operating cash flow in each of the past 5 years.
BRM.CA Yearly Net Income VS EBIT VS OCF VS FCFBRM.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1M -1M 2M 3M 4M

1.2 Ratios

  • The Return On Assets of BRM (7.60%) is better than 91.30% of its industry peers.
  • With an excellent Return On Equity value of 17.30%, BRM belongs to the best of the industry, outperforming 86.96% of the companies in the same industry.
  • BRM's Return On Invested Capital of 15.98% is amongst the best of the industry. BRM outperforms 100.00% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for BRM is significantly above the industry average of 5.93%.
  • The last Return On Invested Capital (15.98%) for BRM is well below the 3 year average (25.13%), which needs to be investigated, but indicates that BRM had better years and this may not be a problem.
Industry RankSector Rank
ROA 7.6%
ROE 17.3%
ROIC 15.98%
ROA(3y)9.17%
ROA(5y)8.76%
ROE(3y)32.25%
ROE(5y)35.65%
ROIC(3y)25.13%
ROIC(5y)23.46%
BRM.CA Yearly ROA, ROE, ROICBRM.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

1.3 Margins

  • With a decent Profit Margin value of 6.08%, BRM is doing good in the industry, outperforming 73.91% of the companies in the same industry.
  • In the last couple of years the Profit Margin of BRM has grown nicely.
  • BRM's Operating Margin of 8.87% is fine compared to the rest of the industry. BRM outperforms 78.26% of its industry peers.
  • BRM's Operating Margin has improved in the last couple of years.
  • BRM's Gross Margin of 24.25% is in line compared to the rest of the industry. BRM outperforms 43.48% of its industry peers.
  • In the last couple of years the Gross Margin of BRM has grown nicely.
Industry RankSector Rank
OM 8.87%
PM (TTM) 6.08%
GM 24.25%
OM growth 3Y7.19%
OM growth 5YN/A
PM growth 3Y15.35%
PM growth 5YN/A
GM growth 3Y1.79%
GM growth 5Y2.67%
BRM.CA Yearly Profit, Operating, Gross MarginsBRM.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. BRM.CA Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so BRM is creating value.
  • Compared to 1 year ago, BRM has more shares outstanding
  • The number of shares outstanding for BRM has been reduced compared to 5 years ago.
  • BRM has a better debt/assets ratio than last year.
BRM.CA Yearly Shares OutstandingBRM.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
BRM.CA Yearly Total Debt VS Total AssetsBRM.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

  • BRM has an Altman-Z score of 3.82. This indicates that BRM is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 3.82, BRM belongs to the top of the industry, outperforming 86.96% of the companies in the same industry.
  • The Debt to FCF ratio of BRM is 1.39, which is an excellent value as it means it would take BRM, only 1.39 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of BRM (1.39) is better than 95.65% of its industry peers.
  • A Debt/Equity ratio of 0.20 indicates that BRM is not too dependend on debt financing.
  • BRM's Debt to Equity ratio of 0.20 is amongst the best of the industry. BRM outperforms 86.96% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 1.39
Altman-Z 3.82
ROIC/WACC2.08
WACC7.68%
BRM.CA Yearly LT Debt VS Equity VS FCFBRM.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M

2.3 Liquidity

  • BRM has a Current Ratio of 1.89. This is a normal value and indicates that BRM is financially healthy and should not expect problems in meeting its short term obligations.
  • BRM has a Current ratio of 1.89. This is amongst the best in the industry. BRM outperforms 86.96% of its industry peers.
  • BRM has a Quick Ratio of 1.73. This is a normal value and indicates that BRM is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.73, BRM belongs to the top of the industry, outperforming 82.61% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.89
Quick Ratio 1.73
BRM.CA Yearly Current Assets VS Current LiabilitesBRM.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. BRM.CA Growth Analysis

3.1 Past

  • The earnings per share for BRM have decreased strongly by -64.28% in the last year.
  • The Earnings Per Share has been growing by 32.08% on average over the past years. This is a very strong growth
  • BRM shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -24.88%.
  • BRM shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.63% yearly.
EPS 1Y (TTM)-64.28%
EPS 3Y32.08%
EPS 5YN/A
EPS Q2Q%-47.19%
Revenue 1Y (TTM)-24.88%
Revenue growth 3Y15.2%
Revenue growth 5Y12.63%
Sales Q2Q%-24.4%

3.2 Future

  • Based on estimates for the next years, BRM will show a very strong growth in Earnings Per Share. The EPS will grow by 21.40% on average per year.
  • Based on estimates for the next years, BRM will show a quite strong growth in Revenue. The Revenue will grow by 10.68% on average per year.
EPS Next Y5.26%
EPS Next 2Y21.4%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.42%
Revenue Next 2Y10.68%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
BRM.CA Yearly Revenue VS EstimatesBRM.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M 40M
BRM.CA Yearly EPS VS EstimatesBRM.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 0.05 0.1 0.15 0.2 0.25

More info and screens

Find the best growth stocksShow best growing peers

6

4. BRM.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 23.64, the valuation of BRM can be described as rather expensive.
  • Based on the Price/Earnings ratio, BRM is valued a bit cheaper than the industry average as 78.26% of the companies are valued more expensively.
  • BRM is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 25.79, which is the current average of the S&P500 Index.
  • BRM is valuated reasonably with a Price/Forward Earnings ratio of 9.02.
  • Based on the Price/Forward Earnings ratio, BRM is valued cheaper than 95.65% of the companies in the same industry.
  • BRM's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.80.
Industry RankSector Rank
PE 23.64
Fwd PE 9.02
BRM.CA Price Earnings VS Forward Price EarningsBRM.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 78.26% of the companies in the same industry are more expensive than BRM, based on the Enterprise Value to EBITDA ratio.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of BRM indicates a somewhat cheap valuation: BRM is cheaper than 78.26% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 18.83
EV/EBITDA 9.7
BRM.CA Per share dataBRM.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates BRM does not grow enough to justify the current Price/Earnings ratio.
  • The excellent profitability rating of BRM may justify a higher PE ratio.
  • A more expensive valuation may be justified as BRM's earnings are expected to grow with 21.40% in the coming years.
PEG (NY)4.49
PEG (5Y)N/A
EPS Next 2Y21.4%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BRM.CA Dividend Analysis

5.1 Amount

  • No dividends for BRM!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BRM.CA Fundamentals: All Metrics, Ratios and Statistics

BIOREM INC

TSX-V:BRM (3/18/2026, 7:00:00 PM)

2.6

+0.11 (+4.42%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)11-26
Earnings (Next)03-31
Inst Owners0.16%
Inst Owner ChangeN/A
Ins Owners2%
Ins Owner ChangeN/A
Market Cap41.91M
Revenue(TTM)34.73M
Net Income(TTM)2.11M
Analysts84.44
Price Target3.57 (37.31%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 23.64
Fwd PE 9.02
P/S 1.21
P/FCF 18.83
P/OCF 16.31
P/B 3.44
P/tB 3.44
EV/EBITDA 9.7
EPS(TTM)0.11
EY4.23%
EPS(NY)0.29
Fwd EY11.09%
FCF(TTM)0.14
FCFY5.31%
OCF(TTM)0.16
OCFY6.13%
SpS2.15
BVpS0.76
TBVpS0.76
PEG (NY)4.49
PEG (5Y)N/A
Graham Number1.37
Profitability
Industry RankSector Rank
ROA 7.6%
ROE 17.3%
ROCE 21.09%
ROIC 15.98%
ROICexc 37.31%
ROICexgc 37.31%
OM 8.87%
PM (TTM) 6.08%
GM 24.25%
FCFM 6.41%
ROA(3y)9.17%
ROA(5y)8.76%
ROE(3y)32.25%
ROE(5y)35.65%
ROIC(3y)25.13%
ROIC(5y)23.46%
ROICexc(3y)41.23%
ROICexc(5y)N/A
ROICexgc(3y)41.23%
ROICexgc(5y)N/A
ROCE(3y)33.17%
ROCE(5y)30.97%
ROICexgc growth 3Y-30.69%
ROICexgc growth 5YN/A
ROICexc growth 3Y-30.69%
ROICexc growth 5YN/A
OM growth 3Y7.19%
OM growth 5YN/A
PM growth 3Y15.35%
PM growth 5YN/A
GM growth 3Y1.79%
GM growth 5Y2.67%
F-Score4
Asset Turnover1.25
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 1.39
Debt/EBITDA 0.67
Cap/Depr 66.81%
Cap/Sales 0.99%
Interest Coverage 250
Cash Conversion 71.47%
Profit Quality 105.47%
Current Ratio 1.89
Quick Ratio 1.73
Altman-Z 3.82
F-Score4
WACC7.68%
ROIC/WACC2.08
Cap/Depr(3y)93.69%
Cap/Depr(5y)79.96%
Cap/Sales(3y)1.3%
Cap/Sales(5y)1.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-64.28%
EPS 3Y32.08%
EPS 5YN/A
EPS Q2Q%-47.19%
EPS Next Y5.26%
EPS Next 2Y21.4%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-24.88%
Revenue growth 3Y15.2%
Revenue growth 5Y12.63%
Sales Q2Q%-24.4%
Revenue Next Year5.42%
Revenue Next 2Y10.68%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-59.97%
EBIT growth 3Y23.48%
EBIT growth 5YN/A
EBIT Next Year33.62%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-8.22%
FCF growth 3Y-3.66%
FCF growth 5Y6.73%
OCF growth 1Y-18.62%
OCF growth 3Y-0.86%
OCF growth 5Y7.83%

BIOREM INC / BRM.CA Fundamental Analysis FAQ

What is the fundamental rating for BRM stock?

ChartMill assigns a fundamental rating of 7 / 10 to BRM.CA.


What is the valuation status of BIOREM INC (BRM.CA) stock?

ChartMill assigns a valuation rating of 6 / 10 to BIOREM INC (BRM.CA). This can be considered as Fairly Valued.


How profitable is BIOREM INC (BRM.CA) stock?

BIOREM INC (BRM.CA) has a profitability rating of 9 / 10.


What is the expected EPS growth for BIOREM INC (BRM.CA) stock?

The Earnings per Share (EPS) of BIOREM INC (BRM.CA) is expected to grow by 5.26% in the next year.